What's breaking now, across thousands of outlets.
Plus news about Rezera, ANI Pharmaceuticals, Cloudbreak Pharma and Anaheim Bio. RevMed’s stock jumps on early Rasonque sales: The RAS drug developer reported sales of its pancreatic cancer therapy Rasonque for the first time, netting ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Sequential revenue jumped 77% while cash losses shrank sharply.
Yellow Card, the global stablecoin payments infrastructure provider with operations in Nigeria and other African markets, has acquired Brazilian virtual read more Yellow Card takes Brazil bet as…
Nigeria generated N33 trillion in government revenue between January and October 2026, driven partly by improved digital systems, including electronic invoicing.
First-time homebuyers are not only historically old but also increasingly reliant on family wealth.
Is Greg Abel just getting started, or is this his acquisition approach for the post-Buffett era?
